4.5 Review

Hyperventilation and electroconvulsive therapy: A literature review

Journal

GENERAL HOSPITAL PSYCHIATRY
Volume 50, Issue -, Pages 54-62

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.genhosppsych.2017.09.003

Keywords

Electroconvulsive therapy; Hyperventilation; Hyperoxia; Hypocapnia; Anaesthesia; Review

Categories

Ask authors/readers for more resources

Background: Hyperventilation has been proposed as an augmentation strategy in electroconvulsive therapy (ECT) in accordance with its proconvulsant effect. Objective: This study reviews the existing literature on the application of hyperventilation in ECT, its efficacy, and tolerance. Methods: A systematic search was performed in PubMed and EMBASE databases. Search terms ('electroconvulsive therapy' and 'hyperventilation', 'ventilation', 'hyperoxygenation', 'hyperoxia', 'hypocapnia') were used to retrieve works from 1966 to June 2016. Works that described hyperventilation manoeuvres in ECT settings and their clinical repercussion were included in the review. Results: A total of 17 observational and experimental studies were selected. An important heterogeneity in study designs, samples and ECT conditions, was detected. Findings support a positive influence of hyperventilation on seizure duration, which is the main study variable across different works. Effects of hyperventilation on seizure threshold and quality parameters have been less thoroughly studied. Systematic recording of clinical outcomes and adverse effects of hyperventilation is uncommon. Conclusions: The literature suggests that hyperventilation may be an effective and safe technique to enhance ECT, but many aspects remain to be studied. Further investigations, especially controlled clinical trials, are necessary and should result in a specific and reliable hyperventilation protocol for ECT settings.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Modulation of Limbic and Prefrontal Connectivity by Electroconvulsive Therapy in Treatment-resistant Depression: A Preliminary Study

Marta Cano, Narcis Cardoner, Mikel Urretavizcaya, Ignacio Martinez-Zalacain, Ximena Goldberg, Esther Via, Oren Contreras-Rodriguez, Joan Camprodon, Aida de Arriba-Arnau, Rosa Hernandez-Ribas, Jesus Pujol, Carles Soriano-Mas, Jose M. Menchon

BRAIN STIMULATION (2016)

Article Clinical Neurology

Protocolized hyperventilation enhances electroconvulsive therapy

Aida de Arriba-Arnau, Antonia Dalmau, Virginia Soria, Neus Salvat-Pujol, Carmina Ribes, Ana Sanchez-Allueva, Jose Manuel Menchon, Mikel Urretavizcaya

JOURNAL OF AFFECTIVE DISORDERS (2017)

Article Endocrinology & Metabolism

Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: The role of remission status

Neus Salvat-Pujol, Javier Labad, Mikel Urretavizcaya, Aida de Arriba-Arnau, Cinto Segalas, Eva Real, Alex Ferrer, Jose M. Crespo, Susana Jimenez-Murcia, Caries Soriano-Mas, Jose M. Menchon, Virginia Soria

PSYCHONEUROENDOCRINOLOGY (2017)

Article Psychiatry

Hypocapnia and hyperoxia induction using a hyperventilation protocol in electroconvulsive therapy

Aida de Arriba-Arnau, Antonia Dalmau, Neus Salvat-Pujol, Virginia Soria, Javier Bocos, Jose Manuel Menchon, Mikel Urretavizcaya

REVISTA DE PSIQUIATRIA Y SALUD MENTAL (2017)

Article Clinical Neurology

Early improvement as a predictor of final remission in major depressive disorder: New insights in electroconvulsive therapy

Erika Martinez-Amoros, Ximena Goldberg, Veronica Galvez, Aida de Arriba-Arnau, Virginia Soria, Jose M. Menchon, Diego J. Palao, Mikel Urretavizcaya, Narcis Cardoner

JOURNAL OF AFFECTIVE DISORDERS (2018)

Article Endocrinology & Metabolism

Hypothalamic-pituitary-adrenal axis activity in the comorbidity between obsessive-compulsive disorder and major depression

Javier Labad, Virginia Soria, Neus Salvat-Pujol, Cinto Segalas, Eva Real, Mikel Urretavizcaya, Aida de Arriba-Arnau, Alex Ferrer, Jose M. Crespo, Susana Jimenez-Murcia, Caries Soriano-Mas, Pino Alonso, Jose M. Menchon

PSYCHONEUROENDOCRINOLOGY (2018)

Article Psychiatry

FKBP5 polymorphisms and hypothalamic-pituitary-adrenal axis negative feedback in major depression and obsessive-compulsive disorder

Alex Ferrer, Javier Costas, Javier Labad, Neus Salvat-Pujol, Cinto Segalas, Mikel Urretavizcaya, Eva Real, Aida de Arriba-Arnau, Pino Alonso, Jose M. Crespo, Marta Barrachina, Carles Soriano-Mas, Angel Carracedo, Jose M. Menchon, Virginia Soria

JOURNAL OF PSYCHIATRIC RESEARCH (2018)

Article Psychiatry

BDNF genetic variants and methylation: effects on cognition in major depressive disorder

Alex Ferrer, Javier Labad, Neus Salvat-Pujol, Marta Barrachina, Javier Costas, Mikel Urretavizcaya, Aida de Arriba-Arnau, Jose M. Crespo, Carles Soriano-Mas, Angel Carracedo, Jose M. Menchon, Virginia Soria

TRANSLATIONAL PSYCHIATRY (2019)

Article Clinical Neurology

Similar clinical improvement of depression using 0.5-ms and 1-ms pulse widths in bilateral electroconvulsive therapy

Aida de Arriba-Arnau, Virginia Soria, Neus Salvat-Pujol, Jose M. Menchon, Mikel Urretavizcaya

Summary: The study found that there was no significant difference in the efficacy and number of treatment sessions between groups receiving 0.5-ms and 1-ms pulse width electrical convulsion therapy, suggesting both pulse widths perform similarly in treating depression.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2021)

Article Environmental Sciences

The Role of Sleep Quality, Trait Anxiety and Hypothalamic-Pituitary-Adrenal Axis Measures in Cognitive Abilities of Healthy Individuals

Javier Labad, Neus Salvat-Pujol, Antonio Armario, Angel Cabezas, Aida de Arriba-Arnau, Roser Nadal, Lourdes Martorell, Mikel Urretavizcaya, Jose Antonio Monreal, Jose Manuel Crespo, Elisabet Vilella, Diego Jose Palao, Jose Manuel Menchon, Virginia Soria

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Article Neurosciences

Childhood Maltreatment and Its Interaction with Hypothalamic-Pituitary-Adrenal Axis Activity and the Remission Status of Major Depression: Effects on Functionality and Quality of Life

Neus Salvat-Pujol, Javier Labad, Mikel Urretavizcaya, Aida De Arriba-Arnau, Cinto Segalas, Eva Real, Alex Ferrer, Jose Manuel Crespo, Susana Jimenez-Murcia, Carles Soriano-Mas, Jose Manuel Menchon, Virginia Soria

Summary: Non-remitted patients with major depressive disorder (MDD) exhibited lower functionality and quality of life compared to controls, indicating a partial relationship between depressive symptoms and functionality and quality of life; cortisol measures did not differ between remitted and non-remitted patients; while hypothalamic-pituitary-adrenal (HPA) axis measures and depression remission status were not consistently associated with functionality or quality of life, they moderated the effects of childhood maltreatment on functionality and quality of life.

BRAIN SCIENCES (2021)

Article Neurosciences

Factors Predicting Ictal Quality in Bilateral Electroconvulsive Therapy Sessions

Aida de Arriba-Arnau, Antonia Dalmau Llitjos, Virginia Soria, Stelania Savino, Neus Salvat-Pujol, Jordi Curto, Jose Manuel Menchon, Mikel Urretavizcaya

Summary: In this study, modifiable procedural factors that influence seizure characteristics in ECT sessions were identified, providing potential adjustments to optimize treatment outcomes.

BRAIN SCIENCES (2021)

Article Neurosciences

Can the Addition of Maintenance Electroconvulsive Therapy to Pharmacotherapy Improve Relapse Prevention in Severe Major Depressive Disorder? A Randomized Controlled Trial

Erika Martinez-Amoros, Narcis Cardoner, Veronica Galvez, Aida de Arriba-Arnau, Virginia Soria, Diego J. Palao, Jose M. Menchon, Mikel Urretavizcaya

Summary: This study compared the efficacy and tolerability of pharmacotherapy plus maintenance ECT versus pharmacotherapy alone in preventing MDD relapse. The results showed a lower relapse rate in the M-Pharm/ECT group at nine months compared to the M-Pharm group, but there were no statistically significant differences between the two groups. Subjects without psychotic features were at higher risk of relapse.

BRAIN SCIENCES (2021)

No Data Available